Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Stasi, Antonio Di
MO-TRANS, NCT05429632 / 2021-002864-36: Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT	Active, not recruiting	3	249	Europe, Japan, US, RoW	mocravimod	Priothera SAS, Priothera S.A.S.	Adult Acute Myeloid Leukemia	11/25	11/25
NCT06265584: Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant	Not yet recruiting	2	56	US	ATG dosing platform when combined with standard tacrolimus and mini methotrexate	University of Alabama at Birmingham	Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Disorders	08/28	11/28